These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4451761)

  • 1. The cardiovascular effects of L-dopa in the pithed rat.
    Eden E; Nasmyth PA
    Br J Pharmacol; 1974 Aug; 51(4):473-80. PubMed ID: 4451761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine and L-dopa potentiation of pressor responses to norepinephrine in isolated perfused rat kidneys.
    Lam BK; Stier CT; Wynn NC; Itskovitz HD
    J Cardiovasc Pharmacol; 1986; 8(3):554-8. PubMed ID: 2425172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the mechanism of L-dopa-induced postural hypotension in the cat.
    Dhasmana KM; Spilker BA
    Br J Pharmacol; 1973 Mar; 47(3):437-51. PubMed ID: 4147189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biphasic actions of L-DOPA on the release of endogenous noradrenaline and dopamine from rat hypothalamic slices.
    Goshima Y; Kubo T; Misu Y
    Br J Pharmacol; 1986 Sep; 89(1):229-34. PubMed ID: 3801773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-dopa facilitates the release of endogenous norepinephrine and dopamine via presynaptic beta 1- and beta 2-adrenoceptors under essentially complete inhibition of L-aromatic amino acid decarboxylase in rat hypothalamic slices.
    Goshima Y; Nakamura S; Misu Y
    Jpn J Pharmacol; 1990 May; 53(1):47-56. PubMed ID: 1972204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating levels of corticotrophin and cortisol after infusions of L-DOPA, dopamine and noradrenaline, in man.
    Wilcox CS; Aminoff MJ; Millar JG; Keenan J; Kremer M
    Clin Endocrinol (Oxf); 1975 Mar; 4(2):191-8. PubMed ID: 165915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of the cardiovascular effects of L-dopa by decarboxylase inhibitors.
    Watanabe AM; Parks LC; Kopin IJ
    J Clin Invest; 1971 Jun; 50(6):1322-8. PubMed ID: 5578236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for L-dopa systems responsible for cardiovascular control in the nucleus tractus solitarii of the rat.
    Kubo T; Yue JL; Goshima Y; Nakamura S; Misu Y
    Neurosci Lett; 1992 Jun; 140(2):153-6. PubMed ID: 1501771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An aromatic L-amino acid decarboxylase inhibitor blocks L-dopa-induced air-stepping in neonatal rats.
    Arnaiz CO; Taylor LL; Stehouwer DJ; van Hartesveldt C
    Brain Res Dev Brain Res; 1996 Jul; 94(2):234-7. PubMed ID: 8836582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasting reduces the responses of the rat vas deferens to sympathomimetics.
    Tayo FM
    Arch Int Pharmacodyn Ther; 1984 Feb; 267(2):249-57. PubMed ID: 6712358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of the chronotropic effect of tyramine on rat atria after reserpine.
    Murnaghan MF
    Br J Pharmacol; 1968 Sep; 34(1):88-98. PubMed ID: 4877602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Centrally mediated increased reflex vagal bradycardia after L-dopa in monoamine oxidase-inhibited anesthetized dogs.
    Antonaccio MJ; Kerwin L
    J Pharmacol Exp Ther; 1976 Feb; 196(2):380-8. PubMed ID: 1255483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic analysis of stimulation-evoked overflow of noradrenaline and dopamine beta-hydroxylase from the isolated rabbit heart. The effect of DOPA decarboxylase inhibition.
    Muscholl E; Spira FJ
    Neuroscience; 1982; 7(12):3201-11. PubMed ID: 7162634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of enzyme inhibitors of catecholamine metabolism and of haloperidol on the pancreatic secretion induced by L-DOPA and by dopamine in dogs.
    Furuta Y; Hashimoto K; Iwatsuki K; Takeuchi O
    Br J Pharmacol; 1973 Jan; 47(1):77-84. PubMed ID: 4717022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of amezinium, a novel antihypotensive drug. III. Studies on the mechanism of action.
    Lenke D; Gries J; Kretzschmar R
    Arzneimittelforschung; 1981; 31(9a):1558-65. PubMed ID: 7197970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The action of L-DOPA on the spontaneous activity generated by the isolated spinal cord of 16- to 20-day-old chick embryos].
    Chub NL
    Neirofiziologiia; 1991; 23(3):338-43. PubMed ID: 1679202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulatory effects of L-DOPA on D2 dopamine receptors in rat striatum, measured using in vivo microdialysis and PET.
    Opacka-Juffry J; Ashworth S; Ahier RG; Hume SP
    J Neural Transm (Vienna); 1998; 105(4-5):349-64. PubMed ID: 9720967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new dopamine- -hydroxylase inhibitor: effects on the noradrenaline concentration and on the action of L-DOPA in the spinal cord.
    Andén NE; Fuxe K
    Br J Pharmacol; 1971 Dec; 43(4):747-56. PubMed ID: 4339882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mediation of enhanced reflex vagal bradycardia by L-dopa via central dopamine formation in dogs.
    Antonaccio MJ; Kerwin L
    Arch Int Pharmacodyn Ther; 1977 Mar; 226(1):56-68. PubMed ID: 869641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of various agents on the pressor response to dopa in the anesthetized dog.
    Pruss TP; McGill JS
    Eur J Pharmacol; 1969 Oct; 8(1):14-8. PubMed ID: 4391043
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.